Is a complete TRLV research report available?

No complete published report is available for Trulieve Cannabis Corp. (TRLV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Trulieve Cannabis Corp. (TRLV)

NYSE: TRLV · USD

$10.6

-0.05 (-0.5%)· Recorded snapshot

Market cap	2B
Revenue (ttm)	1.1B
Net income (ttm)	-473.3M
EPS (ttm)	-$2.46
Shares out	192.6M
P/E (forward)	23.5x
Volume	1,014,669
Beta	1.80

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.1B
Net income (ttm): -473.3M
EPS (ttm): -$2.46
P/E (forward): 23.5x
Market cap: 2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001754195
Company name	Trulieve Cannabis Corp.
Country	United States
Country code	US
CUSIP number	89790E106
Earnings date	2026-11-05
Earnings time	bmo
Employees	5,000
Employees change	-1,000
Employees growth	-16.67%
Enterprise value	$2.3B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	December
Founded	1940
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	US89790E1064
Last earnings date	2026-08-07
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2B
Market cap category	Mid-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$10.62
Price currency	USD
Sector	Healthcare
Stock price date	2026-10-28
Symbol	TRLV
U.S. state	Florida
Website	https://www.trulieve.com

Metric

Value

Amount currency

USD

CIK code

0001754195

Company name

Trulieve Cannabis Corp.

Country

United States

Country code

CUSIP number

89790E106

Earnings date

2026-11-05

Earnings time

bmo

Employees

5,000

Employees change

-1,000

Employees growth

-16.67%

Enterprise value

$2.3B

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-07-12

Fiscal year end

December

Founded

1940

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Yes

Is SPAC

ISIN number

US89790E1064

Last earnings date

2026-08-07

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$2B

Market cap category

Mid-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$10.62

Price currency

USD

Sector

Healthcare

Stock price date

2026-10-28

Symbol

TRLV

U.S. state

Florida

Website

https://www.trulieve.com

Metric	Value
Adjusted P/E ratio	88.5x
Earnings yield	-23.21%
EV/EBIT	17.54x
EV/EBITDA	7.64x
EV/FCF	11.35x
EV/Sales	2.02x
FCF / EV yield	8.81%
FCF yield	9.9%
Forward EV/Sales	2.51x
Forward P/E	23.51x
Forward P/S	2.23x
Industry forward P/E	13.86x
Industry P/E	173.47x
P/(FCF - SBC) ratio	11.26x
P/(OCF - SBC) ratio	9.15x
P/B ratio	2.67x
P/FCF ratio	10.11x
P/OCF ratio	8.37x
P/S ratio	1.8x
Price / tangible book value	14.48x
Price/EBITDA ratio	6.8x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

88.5x

Earnings yield

-23.21%

EV/EBIT

17.54x

EV/EBITDA

7.64x

EV/FCF

11.35x

EV/Sales

2.02x

FCF / EV yield

8.81%

FCF yield

9.9%

Forward EV/Sales

2.51x

Forward P/E

23.51x

Forward P/S

2.23x

Industry forward P/E

13.86x

Industry P/E

173.47x

P/(FCF - SBC) ratio

11.26x

P/(OCF - SBC) ratio

9.15x

P/B ratio

2.67x

P/FCF ratio

10.11x

P/OCF ratio

8.37x

P/S ratio

1.8x

Price / tangible book value

14.48x

Price/EBITDA ratio

6.8x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	11.51%
EBITDA margin	26.43%
FCF margin	17.78%
Gross margin	59.47%
Operating margin	11.51%
Pretax margin	-28.61%
Profit margin	-41.55%
Profit per employee	$-94,660
Revenue per employee	$227,808
ROA	3.28%
ROA (5Y)	3.5%
ROCE	6.61%
ROE	-47.66%
ROE (5Y)	-10.83%
ROIC	10.72%
ROIC (5Y)	-3.63%
SBC / revenue	1.83%
Tax / revenue	12.71%

Metric

Value

EBIT margin

11.51%

EBITDA margin

26.43%

FCF margin

17.78%

Gross margin

59.47%

Operating margin

11.51%

Pretax margin

-28.61%

Profit margin

-41.55%

Profit per employee

$-94,660

Revenue per employee

$227,808

ROA

3.28%

ROA (5Y)

3.5%

ROCE

6.61%

ROE

-47.66%

ROE (5Y)

-10.83%

ROIC

10.72%

ROIC (5Y)

-3.63%

SBC / revenue

1.83%

Tax / revenue

12.71%

Metric	Value
EPS growth years	2
FCF growth	151.28%
FCF growth (Q)	-54.15%
FCF growth (QoQ)	-23.9%
Gross profit growth	-6.75%
Gross profit growth (Q)	-11.28%
Gross profit growth 3Y	3.06%
Gross profit growth 5Y	6.14%
Net income growth years	2
OCF growth	23.31%
OCF growth (Q)	-38.28%
OCF growth (QoQ)	-4.6%
OCF growth 3Y	118.71%
OCF growth 5Y	27.99%
Operating income growth	55.54%
Operating income growth (Q)	-33.57%
Operating income growth 3Y	19.26%
Operating income growth 5Y	-14.16%
Revenue growth	-3.9%
Revenue growth (Q)	-10.31%
Revenue growth (QoQ)	-5.51%
Revenue growth 3Y	-0.63%
Revenue growth 5Y	9.8%
Revenue growth years	0

Metric

Value

EPS growth years

FCF growth

151.28%

FCF growth (Q)

-54.15%

FCF growth (QoQ)

-23.9%

Gross profit growth

-6.75%

Gross profit growth (Q)

-11.28%

Gross profit growth 3Y

3.06%

Gross profit growth 5Y

6.14%

Net income growth years

OCF growth

23.31%

OCF growth (Q)

-38.28%

OCF growth (QoQ)

-4.6%

OCF growth 3Y

118.71%

OCF growth 5Y

27.99%

Operating income growth

55.54%

Operating income growth (Q)

-33.57%

Operating income growth 3Y

19.26%

Operating income growth 5Y

-14.16%

Revenue growth

-3.9%

Revenue growth (Q)

-10.31%

Revenue growth (QoQ)

-5.51%

Revenue growth 3Y

-0.63%

Revenue growth 5Y

9.8%

Revenue growth years

Metric	Value
Capital expenditures	$-41.9M
Depreciation and amortization	$170M
EBIT	$131.1M
EBITDA	$301M
EPS	$-2.46
FCF per share	$1.05
Financing cash flow	$-211.1M
Free cash flow	$202.6M
Free cash flow minus SBC	$181.8M
Gross profit	$677.4M
Income taxes	$144.8M
Investing cash flow	$-108.9M
Net borrowing	$-190.9M
Net cash flow	$-75.6M
Net income	$-473.3M
Operating cash flow minus SBC	$223.6M
Operating income	$131.1M
Revenue	$1.1B
Stock-based compensation	$20.8M

Metric

Value

Capital expenditures

$-41.9M

Depreciation and amortization

$170M

EBIT

$131.1M

EBITDA

$301M

EPS

$-2.46

FCF per share

$1.05

Financing cash flow

$-211.1M

Free cash flow

$202.6M

Free cash flow minus SBC

$181.8M

Gross profit

$677.4M

Income taxes

$144.8M

Investing cash flow

$-108.9M

Net borrowing

$-190.9M

Net cash flow

$-75.6M

Net income

$-473.3M

Operating cash flow minus SBC

$223.6M

Operating income

$131.1M

Revenue

$1.1B

Stock-based compensation

$20.8M

Metric	Value
Altman Z-Score	0.78
Book value per share	$3.99
Debt / EBITDA	1.72
Debt / equity	0.75
Debt / FCF	2.85
Goodwill	$325.6M
Interest coverage	2.31
Long-term assets	$1.5B
Long-term liabilities	$1.2B
Net cash (debt)	$-252.5M
Net cash / market cap	-12.33%
Net debt / EBITDA	0.84
Net debt / equity	0.33
Net debt / FCF	1.25
Piotroski F-Score	6
Property, plant and equipment	$724.9M
Shareholders' equity	$765.9M
Tangible book value	$141.4M
Tangible book value per share	$0.73
Total assets	$2.1B
Total cash	$325.4M
Total debt	$577.9M
Total liabilities	$1.3B
WACC	12.77%

Metric

Value

Altman Z-Score

0.78

Book value per share

$3.99

Debt / EBITDA

1.72

Debt / equity

0.75

Debt / FCF

2.85

Goodwill

$325.6M

Interest coverage

2.31

Long-term assets

$1.5B

Long-term liabilities

$1.2B

Net cash (debt)

$-252.5M

Net cash / market cap

-12.33%

Net debt / EBITDA

0.84

Net debt / equity

0.33

Net debt / FCF

1.25

Piotroski F-Score

Property, plant and equipment

$724.9M

Shareholders' equity

$765.9M

Tangible book value

$141.4M

Tangible book value per share

$0.73

Total assets

$2.1B

Total cash

$325.4M

Total debt

$577.9M

Total liabilities

$1.3B

WACC

12.77%

Metric	Value
Asset turnover	0.46
Current assets	$564.8M
Current liabilities	$95.1M
Current ratio	5.94
Inventory turnover	2.16
Net working capital	$170.6M
Quick ratio	3.71
Working capital	$469.8M
Working capital turnover	2.15

Metric

Value

Asset turnover

0.46

Current assets

$564.8M

Current liabilities

$95.1M

Current ratio

5.94

Inventory turnover

2.16

Net working capital

$170.6M

Quick ratio

3.71

Working capital

$469.8M

Working capital turnover

2.15

Metric	Value
Buyback yield / dilution	-0.75%
Dividend yield	0%
Shareholder yield	-0.75%

Metric

Value

Buyback yield / dilution

-0.75%

Dividend yield

Shareholder yield

-0.75%

Metric	Value
150-day SMA	$9.44
1D price change	-0.47%
1M price change	-14.95%
1M total return	-14.95%
1W price change	-3.75%
1W total return	-3.75%
1Y price change	41.68%
1Y return CAGR	41.71%
1Y total return	41.68%
20-day SMA	$10.54
200-day SMA	$8.80
3M price change	24.67%
3M total return	24.67%
3Y price change	169.74%
3Y return CAGR	39.19%
3Y total return	169.74%
50-day SMA	$11.18
50-day SMA vs 200-day SMA	50over200
52-week high	$13.28
52-week high date	2026-06-09
52-week low	$4.62
52-week low date	2025-11-19
5Y price change	-58.54%
5Y return CAGR	-16.15%
5Y total return	-58.54%
6M price change	10.24%
6M total return	10.24%
All-time high	$53.73
All-time high date	2021-03-18
All-time low	$3.02
All-time low date	2025-04-07
Average true range (ATR)	$0.66
Average volume	1.4M
Beta (1Y)	0.4
Beta (2Y)	0.73
Beta (5Y)	1.8
Change from 52-week high	-20.03%
Change from 52-week low	130.07%
Change from all-time high	-80.67%
Change from all-time low	243.87%
Change from open	0.66%
Day's gap	-1.12%
Dollar volume	$10.8M
High price	$10.75
Low price	$10.39
Monthly RSI	54.9
Open price	$10.55
Position in 52-week range	63.89%
Premarket change	-1.12%
Premarket close	$10.67
Premarket price	$10.55
Premarket volume	14.1K
Previous close	$10.67
Price vs 150-day SMA	10.03%
Price vs 20-day SMA	-1.46%
Price vs 200-day SMA	18.01%
Price vs 50-day SMA	-7.1%
Relative volume	0.74
RSI	44.98
Sharpe ratio	0.77
Sharpe ratio (3Y)	0.69
Sharpe ratio (5Y)	0.16
Sortino ratio	1.53
Sortino ratio (3Y)	1.24
Sortino ratio (5Y)	0.34
Volume	1M
Weekly RSI	53.5
YTD price change	19.51%
YTD total return	19.51%

Metric

Value

150-day SMA

$9.44

1D price change

-0.47%

1M price change

-14.95%

1M total return

-14.95%

1W price change

-3.75%

1W total return

-3.75%

1Y price change

41.68%

1Y return CAGR

41.71%

1Y total return

41.68%

20-day SMA

$10.54

200-day SMA

$8.80

3M price change

24.67%

3M total return

24.67%

3Y price change

169.74%

3Y return CAGR

39.19%

3Y total return

169.74%

50-day SMA

$11.18

50-day SMA vs 200-day SMA

50over200

52-week high

$13.28

52-week high date

2026-06-09

52-week low

$4.62

52-week low date

2025-11-19

5Y price change

-58.54%

5Y return CAGR

-16.15%

5Y total return

-58.54%

6M price change

10.24%

6M total return

10.24%

All-time high

$53.73

All-time high date

2021-03-18

All-time low

$3.02

All-time low date

2025-04-07

Average true range (ATR)

$0.66

Average volume

1.4M

Beta (1Y)

0.4

Beta (2Y)

0.73

Beta (5Y)

1.8

Change from 52-week high

-20.03%

Change from 52-week low

130.07%

Change from all-time high

-80.67%

Change from all-time low

243.87%

Change from open

0.66%

Day's gap

-1.12%

Dollar volume

$10.8M

High price

$10.75

Low price

$10.39

Monthly RSI

54.9

Open price

$10.55

Position in 52-week range

63.89%

Premarket change

-1.12%

Premarket close

$10.67

Premarket price

$10.55

Premarket volume

14.1K

Previous close

$10.67

Price vs 150-day SMA

10.03%

Price vs 20-day SMA

-1.46%

Price vs 200-day SMA

18.01%

Price vs 50-day SMA

-7.1%

Relative volume

0.74

RSI

44.98

Sharpe ratio

0.77

Sharpe ratio (3Y)

0.69

Sharpe ratio (5Y)

0.16

Sortino ratio

1.53

Sortino ratio (3Y)

1.24

Sortino ratio (5Y)

0.34

Volume

Weekly RSI

53.5

YTD price change

19.51%

YTD total return

19.51%

Metric	Value
Float	167.9M
Float percentage	87.19%
Shares change (QoQ)	0.09%
Shares change (YoY)	0.75%
Shares held by insiders	11.92%
Shares held by institutions	25.82%
Shares outstanding	192.6M
Short % of float	3.83%
Short % of shares	3.34%
Short ratio	2.5 days

Metric

Value

Float

167.9M

Float percentage

87.19%

Shares change (QoQ)

0.09%

Shares change (YoY)

0.75%

Shares held by insiders

11.92%

Shares held by institutions

25.82%

Shares outstanding

192.6M

Short % of float

3.83%

Short % of shares

3.34%

Short ratio

2.5 days

Trulieve Cannabis Corp. (TRLV)

Price

Financial snapshot

Fair-value bridge

Latest news · TRLV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TRLV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TRLV

Frequently asked questions